- Country: USA
- Summary: Atlassian Jira and Confluence Enterprise Renewal Brand Name restriction
- UST Ref No: 133594180
- Deadline: 14 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFQ-CC-26-000701
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Acquisition Description:
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested.
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-04.
The Solicitation number is RFQ-CC-26-000701 and the solicitation is issued as a Request for Quotes (RFQ).
_________________________________________________________________________________________________________
The National Institutes of Health (NIH) Clinical Center (CC), Department of Clinical Research Informatics (DCRI), utilizes Atlassian Jira Software and Confluence as core platforms for IT Governance, Quality Management, and critical system documentation. The continuity of these platforms is essential for regulatory compliance and system stability. A renewal of this software is required.
Justification: The Jira workflows supporting Master Control and clinical manufacturing have been rigorously developed, configured, tested, and validated to meet stringent FDA audit and compliance standards. Migrating this workflow to a different platform would require a complete re-validation of the new system, including drafting new System Security Plans (SSPs), developing new audit trails, training all affected staff (including Quality Assurance and Clinical Manufacturing personnel), and re-integrating with Master Control. The estimated cost and time associated with this re-validation and regula... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAtlassian Jira and Confluence Enterprise Renewal Brand Name restriction - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Atlassian Jira and Confluence Enterprise Renewal Brand Name restriction. This tender is published on USARFP under UST Ref No: 133594180 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
